Rituximab Plus Venetoclax in Front Line Marginal Zone Lymphoma
Clinical trial NCT06510309 · RECRUITING
Trial details
- NCT number
- NCT06510309
- Sponsor
- Gottfried von Keudell, MD PhD
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-11
- Primary completion
- 2028-10-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.